DaVita (DVA)
(Delayed Data from NYSE)
$138.54 USD
+6.29 (4.76%)
Updated May 24, 2024 04:00 PM ET
After-Market: $138.53 -0.01 (-0.01%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth B Momentum A VGM
Brokerage Reports
0 items in cart
DaVita Inc. [DVA]
Reports for Purchase
Showing records 121 - 140 ( 286 total )
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Healthcare Services: Tax Reform Positive Near Term; Mixed Bag Longer Term
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Reducing Estimates on AKF Commercial Rate Pushback.
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Morning Call
Provider: KEYBANC CAPITAL MARKETS